Farmaè S.p.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 116.31 million compared to EUR 82.48 million a year ago. Net loss was EUR 0.907556 million compared to EUR 0.08971 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.94 EUR | -0.34% | -2.94% | -32.04% |
05-29 | Talea Group chooses Integrae SIM as new Euronext Growth Advisor | AN |
05-27 | Talea grants additional options under stock option plan | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.04% | 44.05M | |
+2.35% | 208B | |
+1.07% | 189B | |
+9.80% | 87.48B | |
+28.33% | 83.28B | |
-24.07% | 76.22B | |
+8.29% | 51.06B | |
+24.35% | 27.46B | |
+29.94% | 11.13B | |
-9.46% | 8.72B |
- Stock Market
- Equities
- FAR Stock
- News Talea Group S.p.A.
- Farmaè S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022